## APPN: Appian Corporation - XLK: Technology

### Executive Summary

VALUE thesis: PEG 0.12 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-10.5% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($35.84)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 1
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Appian (APPN): Assessing Valuation After Healthcare AI Recognition and HL7 AI Challenge Win**
- Source: Sahm | 20251201T052234 | Somewhat-Bullish | Relevance: 100%
- Appian (APPN) recently gained recognition for its "Bring AI to Work(flow)" solution in healthcare, winning the HL7 AI Challenge and driving a 35.5% share price surge over the last month. While a popular narrative suggests the stock is 2.9% undervalued with a fair value of $41.60, a Discounted Cash Flow (DCF) model indicates it may be trading above fair value, challenging the market's optimism. Investors are navigating the potential upside from AI innovation against inherent market volatility and competitive threats.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-11 | Morgan Stanley | $45 | $29 | +55% |
| 2025-11-07 | Barclays | $37 | $33 | +12% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-11 | Morgan Stanley | main | Equal-Weight |
| 2025-11-07 | Barclays | main | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 9 ($0.00M) |
| Sells | 2 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 13.9% (+13.0%)
- Blackrock Inc.: 8.0% (+6.7%)
- Lead Edge Capital Ma: 4.2% (+11.5%)
- Abdiel Capital Advis: 3.1% (-82.8%)
- Arrowstreet Capital,: 3.0% (+86.9%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-10.5% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.12 indicates undervaluation relative to growth. Analyst sentiment positive (2 raises, avg +34%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $2.6B |
| Beta | 0.85 |
| 52W Range | $24.00 - $46.06 |
| Short Interest | 7.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.12 |
| Forward P/E | 51.2 |
| Current P/E | 72.7 |
| YoY Growth | 42.0% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 5.0% to -5.5% (-10.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 9.5pp (needs >4.0% for momentum thesis). AM_20 at -3.7% indicates price below own 20MA trend. Underperforming sector by 5.1pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.26x) but short-term weakness (below SMA20). MACD histogram bearish (-0.57), momentum weakening. RSI neutral at 53. OFD pattern: -MLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -5.52% (CS: 8) | Weak |
| RSI_14 | 53.2 | Neutral |
| MACD Histogram | -0.57 | Bearish |
| vs SMA20 | 0.963x | Below |
| vs SMA50 | 1.148x | Above |
| vs SMA200 | 1.259x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $39.40
- **Stop Loss:** $35.84 (9.0% risk)
- **Target:** $46.52 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 266
- **Position Value:** $10,480.40
- **Portfolio %:** 10.48%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderately constructive conditions. Fed dovish pivot expectations from weak jobs data and declining VIX suggest improving risk appetite, though narrow breadth at 51% indicates selective participation. Focus on quality sectors benefiting from rate cut expectations.*

### Earnings

**Next:** 2026-02-18 (Est: $0.08)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.05 | $0.32 | +490.0% |
| 2025Q2 | $-0.13 | $0.00 | +103.0% |
| 2025Q1 | $0.03 | $0.13 | +315.7% |
| 2024Q4 | $-0.01 | $0.00 | +100.0% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*